BioCentury
ARTICLE | Clinical News

Anti-dengue nanoviricides regulatory update

November 25, 2013 8:00 AM UTC

NanoViricides said the European Commission granted Orphan Drug designation for DengueCide to treat dengue and dengue hemorrhagic fever. The vaccine is in preclinical testing and has Orphan Drug design...